Stock Events

Stock Events

Apontis Pharma

€11

9

-€0.05-0.45% Thursday 16:30

Statistics

Day High

11.05

Day Low

11.05

52W High

12.1

52W Low

9.64

Volume

354

Avg. Volume

-

Mkt Cap

0

P/E Ratio

136.25

Dividend Yield

-

Dividend

-

Earnings

14AugExpected

Q4 2023

Q2 2024

Q4 2024

Q2 2025

999

333

-333

-999

Expected EPS

N/A

Actual EPS

N/A

Financials

1.56%Profit Margin

Profitable

2020

2021

2022

2023

2024

48.47MRevenue

754,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow APPH.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Apontis Pharma in various therapeutic areas.

Pfizer is a large pharmaceutical company with a wide range of products that compete with Apontis Pharma's offerings, especially in the prescription drug market.

Merck & Co., Inc. is known for its innovative medicines and vaccines, competing with Apontis Pharma in areas such as healthcare and pharmaceuticals.

GlaxoSmithKline is a global healthcare company that produces pharmaceuticals and vaccines, competing with Apontis Pharma in multiple therapeutic areas.

Johnson & Johnson

Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, making it a competitor across several of Apontis Pharma's business lines.

AbbVie is a research-based biopharmaceutical company that competes with Apontis Pharma in developing and marketing advanced therapies.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that compete with Apontis Pharma.

Sanofi is a global healthcare leader that discovers, develops, and distributes therapeutic solutions, competing with Apontis Pharma in the pharmaceutical sector.

Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics, directly competing with Apontis Pharma in the healthcare market.

AstraZeneca is a global, science-led biopharmaceutical business that competes with Apontis Pharma in developing and commercializing prescription medicines.

About

Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.

Show more...

CEO

Mr. Thomas Milz

Employees

137

Country

Germany

ISIN

DE000A3CMGM5

WKN

000A3CMGM

Listings

0 Comments

Share your thoughts

FAQ

What is Apontis Pharma stock price today?▼

The current price of APPH.XETRA is €11 EUR — it has decreased by -0.45% in the past 24 hours. Watch Apontis Pharma stock price performance more closely on the chart.

What is Apontis Pharma stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Apontis Pharma stocks are traded under the ticker APPH.XETRA.

Is Apontis Pharma stock price growing?▼

APPH.XETRA stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Apontis Pharma has showed a -1.79% decrease.

What is Apontis Pharma revenue for the last year?▼

Apontis Pharma revenue for the last year amounts to 48.47M EUR.

What is Apontis Pharma net income for the last year?▼

APPH.XETRA net income for the last year is 754,000 EUR.

How many employees does Apontis Pharma have?▼

As of April 29, 2026, the company has 137 employees.

In which sector is Apontis Pharma located?▼

Apontis Pharma operates in the Health & Wellness sector.

When did Apontis Pharma complete a stock split?▼

Apontis Pharma has not had any recent stock splits.

Where is Apontis Pharma headquartered?▼

Apontis Pharma is headquartered in Monheim am Rhein, Germany.